神州细胞(688520)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

688520 神州细胞

已收盘 07-19 15:00:00

{"stockData":{"symbol":"688520","market":"SH","secType":"STK","nameCN":"神州细胞","latestPrice":40.3,"timestamp":1721372400000,"preClose":40.29,"halted":0,"volume":1132148,"delay":0,"floatShares":445000000,"shares":445000000,"eps":-0.3791,"marketStatus":"已收盘","marketStatusCode":5,"change":0.01,"latestTime":"07-19 15:00:00","open":40.21,"high":40.97,"low":39.7,"amount":45653100,"amplitude":0.0315,"askPrice":40.33,"askSize":6,"bidPrice":40.3,"bidSize":360,"shortable":0,"etf":0,"ttmEps":-0.3791,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1721611800000},"adr":0,"adjPreClose":40.29,"symbolType":"stock_kcb","openAndCloseTimeList":[[1721352600000,1721359800000],[1721365200000,1721372400000]],"highLimit":44.32,"lowLimit":36.26,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":445335714,"pbRate":-34.77,"roa":"--","roe":"0.0%","epsLYR":-0.89,"committee":0.635688,"marketValue":17947000000,"floatMarketCap":17947000000,"peRate":-106.304407,"changeRate":0.0002,"turnoverRate":0.0025,"status":0,"nextConnectDate":"根据港交所公布的数据，今日已停止北向交易，下一个交易日为北京时间 2024-07-22。","afterMarket":{"amount":0,"volume":0,"close":40.3,"buyVolume":0,"sellVolume":0,"time":1721374439754,"indexStatus":"已收盘 07-19 15:30:00","preClose":40.29}},"requestUrl":"/m/hq/s/688520","defaultTab":"news","newsList":[{"id":"2452498598","title":"北向资金7月18日净买入神州细胞-U7.13万股 连续3日增持","url":"https://stock-news.laohu8.com/highlight/detail?id=2452498598","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452498598?lang=zh_cn&edition=full","pubTime":"2024-07-19 09:30","pubTimestamp":1721352642,"startTime":"0","endTime":"0","summary":"7月18日, 北向资金增持神州细胞-U7.13万股，连续3日增持。截止当日收盘，沪股通共持有神州细胞-U167.68万股，占流通股0.37%。沪股通增持金额前五个股分别为紫金矿业、韦尔股份、赤峰黄金、XD中金黄、长江电力。神州细胞-U近5个交易日下跌2.80%，沪股通累计减持2.23万股；近20个交易日下跌5.22%，沪股通累计减持41.52万股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407190935299f686923&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407190935299f686923&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0019","000159","BK0077","BK0239","BK0028","BK0250","BK0025","BK0029","688520"],"gpt_icon":0},{"id":"2452173797","title":"神州细胞-U07月18日遭主力抛售270万元 环比增加5300.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2452173797","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452173797?lang=zh_cn&edition=full","pubTime":"2024-07-18 15:18","pubTimestamp":1721287121,"startTime":"0","endTime":"0","summary":"07月18日, 神州细胞-U股价跌1.15%，报收40.29元，成交金额6467万元，换手率0.36%，振幅2.55%，量比0.88。神州细胞-U今日主力资金净流出270万元，上一交易日主力净流出5万元，今日环比增加5300.00%。该股近5个交易日下跌2.80%，主力资金累计净流入562万元；近20日主力资金累计净流入303万元，其中净流入天数为11日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024071815292495d3e299&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024071815292495d3e299&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688520","BK0239"],"gpt_icon":0},{"id":"2451951908","title":"神州细胞-U07月16日主力资金流入103万元 连续3日加仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2451951908","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2451951908?lang=zh_cn&edition=full","pubTime":"2024-07-16 15:19","pubTimestamp":1721114375,"startTime":"0","endTime":"0","summary":"07月16日, 神州细胞-U股价涨0.34%，报收40.87元，成交金额4912万元，换手率0.27%，振幅2.21%，量比0.57。神州细胞-U今日主力资金净流入103万元，连续3日净流入，上一交易日主力净流入371万元，今日环比减少72.24%。近一年数据显示，该股主力连续3日净流入后，次日上涨概率为61.54%，平均涨幅为2.57%。该股近5个交易日上涨5.72%，主力资金累计净流入2258万元，其中1个交易日为股价下跌时净流入；近20日主力资金累计净流出57万元，其中净流出天数为8日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024071615355695c5e44d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024071615355695c5e44d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688520"],"gpt_icon":0},{"id":"2451612608","title":"神州细胞：\n公司将积极采取措施在2024年底前使公司净资产转正，避免退市警示风险","url":"https://stock-news.laohu8.com/highlight/detail?id=2451612608","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2451612608?lang=zh_cn&edition=full","pubTime":"2024-07-15 18:02","pubTimestamp":1721037733,"startTime":"0","endTime":"0","summary":"证券之星消息，神州细胞07月15日在投资者关系平台上答复投资者关心的问题。公司将积极采取措施在2024年底前使公司净资产转正，避免退市警示风险。关于公司业绩情况，请关注公司后续相关公告。本文为数据整理，不对您构成任何投资建议，投资有风险，请谨慎决策。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024071500023961.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688520"],"gpt_icon":0},{"id":"2451766562","title":"神州细胞-U大跌5% 北向资金连续3日增持","url":"https://stock-news.laohu8.com/highlight/detail?id=2451766562","media":"智选洞察","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2451766562?lang=zh_cn&edition=full","pubTime":"2024-07-15 10:18","pubTimestamp":1721009898,"startTime":"0","endTime":"0","summary":"07月15日，神州细胞-U股价大幅下跌，截至10点18分，神州细胞-U下跌5.00%，报40.44元/股，成交5185万元，换手率0.28%，振幅4.25%。资金动向截止发稿，神州细胞-U获得主力净流入122万元，其中超大单流出548万元，大单流入671万元。北向资金方面，神州细胞-U07月12日获得北向资金增持0.53万股，截至07月12日，北向资金当前共持有神州细胞-U170.43万股，市值6892万元，持股占流通股比为0.38%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240715101846aef9a676&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240715101846aef9a676&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688520"],"gpt_icon":0},{"id":"2450987871","title":"北向资金7月10日净卖出神州细胞-U12.25万股 连续3日减持","url":"https://stock-news.laohu8.com/highlight/detail?id=2450987871","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450987871?lang=zh_cn&edition=full","pubTime":"2024-07-11 09:30","pubTimestamp":1720661442,"startTime":"0","endTime":"0","summary":"7月10日，北向资金减持神州细胞-U12.25万股连续3日减持。截止当日收盘，沪股通共持有神州细胞-U168.49万股，占流通股0.37%。沪股通减持金额前五个股分别为赛力斯、北汽蓝谷、中国石化、中国铝业、伊利股份。神州细胞-U近5个交易日上涨3.43%，沪股通累计减持34.83万股；近20个交易日下跌6.34%，沪股通累计减持39.97万股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024071109360595a2ae37&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024071109360595a2ae37&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0028","BK0019","688520","BK0239","BK0077","BK0250","000159","BK0029","BK0025"],"gpt_icon":0},{"id":"2450833850","title":"7月10日神州细胞-U涨5.38%，国新国证融泽6个月定开混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2450833850","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450833850?lang=zh_cn&edition=full","pubTime":"2024-07-10 16:10","pubTimestamp":1720599052,"startTime":"0","endTime":"0","summary":"证券之星消息，7月10日神州细胞-U涨5.38%，收盘报40.74元，换手率0.55%，成交量2.45万手，成交额9837.88万元。重仓神州细胞-U的公募基金请见下表：该股最近90天内共有7家机构给出评级，买入评级7家；过去90天内机构目标均价为59.63。根据2024基金Q1季报公募基金重仓股数据，重仓该股的公募基金共1家，其中持有数量最多的公募基金为国新国证融泽6个月定开混合A。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024071000032819.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688520","BK0239"],"gpt_icon":0},{"id":"2450850882","title":"神州细胞-U涨5.38%，华福证券二个月前给出“买入”评级，目标价62.84元","url":"https://stock-news.laohu8.com/highlight/detail?id=2450850882","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450850882?lang=zh_cn&edition=full","pubTime":"2024-07-10 16:10","pubTimestamp":1720599043,"startTime":"0","endTime":"0","summary":"今日神州细胞-U涨5.38%，收盘报40.74元。2024年4月28日，华福证券研究员盛丽华发布了对神州细胞的研报《24年一季报点评：重组VIII因子持续高增长，全年业绩有望持续释放》，该研报对神州细胞给出“买入”评级，认为其目标价为62.84元，现价距离目标价尚有54.25%的涨幅空间。给予公司2024年10倍PS，合理市值为280亿，对应目标价格为62.84元，维持“买入”评级。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024071000032813.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688520","161027"],"gpt_icon":0},{"id":"2450983059","title":"神州细胞-U大幅上涨 获北向资金减持2.42万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2450983059","media":"智选洞察","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450983059?lang=zh_cn&edition=full","pubTime":"2024-07-10 13:52","pubTimestamp":1720590747,"startTime":"0","endTime":"0","summary":"07月10日，神州细胞-U股价大幅上涨，截至13点52分，神州细胞-U上涨5.02%，报40.60元/股，突破40元整数关口，成交6361万元，换手率0.36%，振幅5.41%。资金动向截止发稿，神州细胞-U获得主力净流入772万元，其中超大单流入564万元，大单流入207万元。北向资金方面，神州细胞-U07月09日获得北向资金减持2.42万股，截至07月09日，北向资金当前共持有神州细胞-U180.74万股，市值7338万元，持股占流通股比为0.40%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240710135236aef8e30b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240710135236aef8e30b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688520"],"gpt_icon":0},{"id":"2450884849","title":"生物疫苗概念盘中拉升，神州细胞-U涨1.22%","url":"https://stock-news.laohu8.com/highlight/detail?id=2450884849","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450884849?lang=zh_cn&edition=full","pubTime":"2024-07-10 09:44","pubTimestamp":1720575854,"startTime":"0","endTime":"0","summary":"07月10日，生物疫苗概念盘中拉升，截至09点44分，生物疫苗概念整体指数上涨0.60%，报1637.780点。从个股上来看，该概念的成分股中，神州细胞-U涨1.22%，康泰生物、东方嘉盛、沃森生物涨幅居前。从资金上来看，截止发稿，生物疫苗概念主力净流入为-2284.23万，其中德展健康受到资金热捧，主力净流入126.10万；拉长时间线来看，该板块近20日主力资金净流入-27.18亿。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240710094414af917764&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240710094414af917764&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","159657","688520"],"gpt_icon":0},{"id":"2450701785","title":"神州细胞、晟斯生物、赛诺菲、诺和诺德，血友病创新药竞速","url":"https://stock-news.laohu8.com/highlight/detail?id=2450701785","media":"医药经济报","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450701785?lang=zh_cn&edition=full","pubTime":"2024-07-09 18:41","pubTimestamp":1720521663,"startTime":"0","endTime":"0","summary":"近来，血友病赛道各路人马动作频频。因此，血友病治疗亟需更多创新产品满足患者需求。Centerwatch数据库显示，FDA目前已经批准了13款用于治疗血友病A及其症状的药物。目前，诺和诺德已手握9款血友病药物，欲打造除GLP-1减肥药外的新增长引擎。在国内，腾讯看中的晟斯生物目前有4款自主研发的血友病长效药物已进入临床和产业化阶段。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407091843539596a1c2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407091843539596a1c2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","159992","688520","NVO"],"gpt_icon":0},{"id":"2449728809","title":"神州细胞-U07月08日主力资金流入72万元 连续5日加仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2449728809","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2449728809?lang=zh_cn&edition=full","pubTime":"2024-07-08 15:18","pubTimestamp":1720423113,"startTime":"0","endTime":"0","summary":"07月08日, 神州细胞-U股价跌4.65%，报收38.53元，成交金额7587万元，换手率0.43%，振幅5.86%，量比1.55。神州细胞-U今日主力资金净流入72万元，连续5日净流入，上一交易日主力净流入399万元，今日环比减少81.95%。近一年数据显示，该股主力连续5日净流入后，次日上涨概率为33.33%，平均涨幅为1.38%。该股近5个交易日下跌3.89%，主力资金累计净流入1392万元；近20日主力资金累计净流出2002万元，其中净流出天数为10日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407081530479f1d1f5a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407081530479f1d1f5a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688520"],"gpt_icon":0},{"id":"2449745168","title":"神州细胞-U大跌5.02% 北向资金连续3日增持","url":"https://stock-news.laohu8.com/highlight/detail?id=2449745168","media":"智选洞察","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2449745168?lang=zh_cn&edition=full","pubTime":"2024-07-08 13:47","pubTimestamp":1720417678,"startTime":"0","endTime":"0","summary":"07月08日，神州细胞-U股价大幅下跌，截至13点47分，神州细胞-U下跌5.02%，报38.38元/股，失守40元整数关口，成交5770万元，换手率0.33%，振幅5.67%。北向资金方面，神州细胞-U07月05日获得北向资金增持6.37万股，截至07月05日，北向资金当前共持有神州细胞-U191.79万股，市值7360万元，持股占流通股比为0.43%。最新财报显示，今年一季报，神州细胞-U实现营业收入6.13亿元，同比增长86.30%，净利润为7,419.74万元，同比增长148.49%，基本每股收益为0.17元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240708134833af90fae2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240708134833af90fae2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688520"],"gpt_icon":0},{"id":"2449153236","title":"神州细胞-U上涨5.0%，报40.74元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2449153236","media":"金融界","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2449153236?lang=zh_cn&edition=full","pubTime":"2024-07-05 14:09","pubTimestamp":1720159751,"startTime":"0","endTime":"0","summary":"7月5日，神州细胞-U盘中上涨5.0%，截至14:09，报40.74元/股，成交6130.13万元，换手率0.35%，总市值181.43亿元。截至3月31日，神州细胞-U股东户数9223，人均流通股4.81万股。2024年1月-3月，神州细胞-U实现营业收入6.13亿元，同比增长86.30%；归属净利润7419.74万元，同比增长148.49%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240705141233957a5a1d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240705141233957a5a1d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688520"],"gpt_icon":0},{"id":"2448492732","title":"新冠药物概念盘中跳水，神州细胞-U跌1.37%","url":"https://stock-news.laohu8.com/highlight/detail?id=2448492732","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448492732?lang=zh_cn&edition=full","pubTime":"2024-07-04 14:12","pubTimestamp":1720073521,"startTime":"0","endTime":"0","summary":"07月04日，新冠药物概念盘中跳水，截至14点11分，新冠药物概念整体指数下跌3.01%，报434.330点。从个股上来看，该概念的成分股中，神州细胞-U跌1.37%，中国医药、步长制药、XD博瑞医跌幅居前。从资金上来看，截止发稿，新冠药物概念主力净流入为-2.17亿，其中复星医药受到资金热捧，主力净流入1008.49万；拉长时间线来看，该板块近20日主力资金净流入-27.06亿。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240704141201aef7e6a8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240704141201aef7e6a8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688520","BK0239"],"gpt_icon":0},{"id":"2447221652","title":"神州细胞（688520）6月28日主力资金净卖出592.05万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2447221652","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2447221652?lang=zh_cn&edition=full","pubTime":"2024-06-29 08:20","pubTimestamp":1719620421,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2024年6月28日收盘，神州细胞报收于39.35元，下跌2.84%，换手率0.38%，成交量1.71万手，成交额6820.09万元。近5日资金流向一览见下表：神州细胞融资融券信息显示，融资方面，当日融资买入237.31万元，融资偿还85.1万元，融资净买入152.21万元。神州细胞主营业务：专注于恶性肿瘤、自身免疫性疾病、感染性疾病和遗传病等多个治疗和预防领域的生物药产品研发和产业化。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024062900012662.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688520","BK0239"],"gpt_icon":0},{"id":"2446915858","title":"北向资金6月24日净买入神州细胞-U24.83万股 连续3日增持","url":"https://stock-news.laohu8.com/highlight/detail?id=2446915858","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446915858?lang=zh_cn&edition=full","pubTime":"2024-06-25 09:30","pubTimestamp":1719279042,"startTime":"0","endTime":"0","summary":"6月24日, 北向资金增持神州细胞-U24.83万股，连续3日增持。截止当日收盘，沪股通共持有神州细胞-U247.04万股，占流通股0.55%。沪股通增持金额前五个股分别为赛力斯、农业银行、海光信息、中国中免、恒瑞医药。神州细胞-U近5个交易日下跌7.20%，沪股通累计增持21.68万股；近20个交易日下跌9.24%，沪股通累计增持64.39万股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024062509344095d494f7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024062509344095d494f7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688520","BK0028","BK0029","BK0239","BK0250","BK0025","000159","BK0019","BK0077"],"gpt_icon":0},{"id":"2446831426","title":"神州细胞获北向资金买入1023.17万元，累计持股247.04万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2446831426","media":"金融界","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446831426?lang=zh_cn&edition=full","pubTime":"2024-06-25 08:01","pubTimestamp":1719273667,"startTime":"0","endTime":"0","summary":"6月25日，巨灵财经数据显示，北向资金24日增持神州细胞预估1023.17万元，累计持股247.04万股，总计持有市值9995.11万元，占流通股比例0.55%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202406250805189f61a9a9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202406250805189f61a9a9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688520","BK0239"],"gpt_icon":0},{"id":"2445047364","title":"6月24日神州细胞-U跌5.13%，国新国证融泽6个月定开混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2445047364","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2445047364?lang=zh_cn&edition=full","pubTime":"2024-06-24 16:30","pubTimestamp":1719217845,"startTime":"0","endTime":"0","summary":"证券之星消息，6月24日神州细胞-U跌5.13%，收盘报40.46元，换手率0.47%，成交量2.07万手，成交额8539.34万元。重仓神州细胞-U的公募基金请见下表：该股最近90天内共有8家机构给出评级，买入评级8家；过去90天内机构目标均价为59.63。根据2024基金Q1季报公募基金重仓股数据，重仓该股的公募基金共1家，其中持有数量最多的公募基金为国新国证融泽6个月定开混合A。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024062400020953.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688520","BK0239"],"gpt_icon":0},{"id":"2445358043","title":"神州细胞-U创2月新低 近半年13家券商买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2445358043","media":"智选洞察","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2445358043?lang=zh_cn&edition=full","pubTime":"2024-06-24 14:38","pubTimestamp":1719211129,"startTime":"0","endTime":"0","summary":"06月24日，神州细胞-U股价大幅下跌，截至14点38分，神州细胞-U下跌5.04%，报40.50元/股，创近2月新低，成交7717万元，换手率0.42%，振幅4.69%。此外，数据统计显示，近半年内13家券商给予买入建议。资金动向截止发稿，神州细胞-U获得主力净流出2026万元，其中超大单流出1096万元，大单流出928万元。北向资金方面，神州细胞-U06月21日获得北向资金增持11.10万股，截至06月21日，北向资金当前共持有神州细胞-U222.20万股，市值8999万元，持股占流通股比为0.49%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240624143924af8ed628&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240624143924af8ed628&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688520"],"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2020-06-22","address":"北京市通州区北京经济技术开发区科创七街31号院5号楼307","stockEarnings":[{"period":"1week","weight":-0.0533},{"period":"1month","weight":-0.0606},{"period":"3month","weight":-0.0721},{"period":"6month","weight":-0.1484},{"period":"1year","weight":-0.2666},{"period":"ytd","weight":-0.2519}],"companyName":"北京神州细胞生物技术集团股份公司","boardCode":"AI0027","perCapita":"48285股","boardName":"医药制造业","registeredCapital":"44533万元","compareEarnings":[{"period":"1week","weight":0.0037},{"period":"1month","weight":-0.0118},{"period":"3month","weight":-0.0271},{"period":"6month","weight":0.053},{"period":"1year","weight":-0.0591},{"period":"ytd","weight":0.0025}],"survey":"　　北京神州细胞生物技术集团股份公司是致力于研发具备差异化竞争优势生物药的创新型生物制药研发公司，专注于恶性肿瘤、自身免疫性疾病、感染性疾病和遗传病等多个治疗和预防领域的生物药产品研发和产业化。公司的主要产品为重组蛋白药物、抗体药物等。公司在发现及研发创新药的领域拥有较强的能力，自主建立了从靶点蛋白筛选到候选药物的全套创新生物药发现上游技术平台体系。","serverTime":1721470997138,"listedPrice":25.64,"stockholders":"9223人(较上一季度增加0.37%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.25.1","shortVersion":"4.25.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"神州细胞(688520)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供神州细胞(688520)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"神州细胞,688520,神州细胞股票,神州细胞股票老虎,神州细胞股票老虎国际,神州细胞行情,神州细胞股票行情,神州细胞股价,神州细胞股市,神州细胞股票价格,神州细胞股票交易,神州细胞股票购买,神州细胞股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"神州细胞(688520)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供神州细胞(688520)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}